Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'POLYOL PATHWAY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 177 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hansen, SH
      The role of taurine in diabetes and the development of diabetic complications

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    2. Borenshtein, D; Ofri, R; Werman, M; Stark, A; Tritschler, HJ; Moeller, W; Madar, Z
      Cataract development in diabetic sand rats treated with alpha-lipoic acid and its gamma-linolenic acid conjugate

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    3. Mazade, MA; Edwards, MS
      Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes

      MOLECULAR GENETICS AND METABOLISM
    4. Lewis, S; Karrer, J; Saleh, S; Chen, Y; Tan, Z; Hua, D; McGill, J; Pang, YP; Fenwick, B; Brightman, A; Takemoto, D
      Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase C gamma

      MOLECULAR VISION
    5. Iso, K; Tada, H; Kuboki, K; Inokuchi, T
      Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in Type 2 diabetic patients

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    6. Arun, N; Nalini, N
      Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats

      PLANT FOODS FOR HUMAN NUTRITION
    7. Obrosova, IG; Van Huysen, C; Fathallah, L; Cao, XH; Greene, DA; Stevens, MJ
      An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense

      FASEB JOURNAL
    8. Aragno, M; Parola, S; Brignardello, E; Manti, R; Betteto, S; Tamagno, E; Danni, O; Boccuzzi, G
      Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone

      FREE RADICAL BIOLOGY AND MEDICINE
    9. Verrotti, A; Giuva, T; Morgese, G; Chiarelli, F
      New trends in the etiopathogenesis of diabetic peripheral neuropathy

      JOURNAL OF CHILD NEUROLOGY
    10. Kumar, A; Hawkins, KS; Hannan, MA; Ganz, MB
      Activation of PKC-beta(I) in glomerular mesangial cells is associated withspecific NF-kappa B subunit translocation

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    11. Heilig, CW; Kreisberg, JI; Freytag, S; Murakami, T; Ebina, Y; Guo, L; Heilig, K; Loberg, R; Qu, X; Jin, Y; Henry, D; Brosius, FC
      Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1and fibronectin expression

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    12. Takakura, S; Minoura, H; Shimoshige, Y; Minoura, K; Kawamura, I; Fujiwara, T; Saitoh, T; Shimojo, F; Seki, J; Goto, T
      Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy

      DRUG DEVELOPMENT RESEARCH
    13. Maekawa, K; Tanimoto, T; Okada, S; Suzuki, T; Suzuki, T; Yabe-Nishimura, C
      Expression of aldose reductase and sorbitol dehydrogenase genes in Schwanncells isolated from rat: effects of high glucose and osmotic stress

      MOLECULAR BRAIN RESEARCH
    14. Yoshii, H; Uchino, H; Ohmura, C; Watanabe, K; Tanaka, Y; Kawamori, R
      Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity

      DIABETES RESEARCH AND CLINICAL PRACTICE
    15. Nakamura, J; Hamada, Y; Sakakibara, F; Hara, T; Wakao, T; Mori, K; Nakashima, E; Naruse, K; Kamijo, M; Koh, N; Hotta, N
      Physiological and morphometric analyses of neuropathy in sucrose-fed OLETFrats

      DIABETES RESEARCH AND CLINICAL PRACTICE
    16. Hotta, N; Toyota, T; Matsuoka, K; Shigeta, Y; Kikkawa, R; Kaneko, T; Takahashi, A; Sugimura, K; Koike, Y; Ishii, J; Sakamoto, N
      Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy - A 52-week multicenter placebo-controlled double-blind parallel group study

      DIABETES CARE
    17. Sellers, DJ; Chess-Williams, R
      The effect of streptozotocin-induced diabetes on cardiac beta-adrenoceptorsubtypes in the rat

      JOURNAL OF AUTONOMIC PHARMACOLOGY
    18. Ascher, E; Gade, PV; Hingorani, A; Puthukkeril, S; Kallakuri, S; Scheinman, M; Jacob, T
      Thiamine reverses hyperglycemia-induced dysfunction in cultured endothelial cells

      SURGERY
    19. Sobajima, H; Aoki, T; Sassa, H; Suzuki, T; Taniko, K; Makino, M; Mizuno, K; Suzuki, T
      Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes

      PHARMACOLOGY
    20. Obrosova, IG; Stevens, MJ; Lang, HJ
      Diabetes-induced changes in retinal NAD-redox status - Pharmacological modulation and implications for pathogenesis of diabetic retinopathy

      PHARMACOLOGY
    21. Yamamoto, T; Takakura, S; Kawamura, I; Seki, J; Goto, T
      The effects of zenarestat, an aldose reductase inhibitor, on minimal F-wave latency and nerve blood flow in streptozotocin-induced diabetic rats

      LIFE SCIENCES
    22. Kubo, E; Maekawa, K; Tanimoto, T; Fujisawa, S; Akagi, Y
      Biochemical and morphological changes during development of sugar cataractin Otsuka Long-Evans Tokushima fatty (OLETF) rat

      EXPERIMENTAL EYE RESEARCH
    23. Cotter, MA; Mirrlees, DJ; Cameron, NE
      Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    24. Di Mario, U; Pugliese, G
      15(th) Golgi lecture: from hyperglycaemia to the dysregulation of vascularremodelling in diabetes

      DIABETOLOGIA
    25. Cameron, NE; Cotter, MA
      Effects of an extracellular metal chelator on neurovascular function in diabetic rats

      DIABETOLOGIA
    26. Johansson, K; El-Ahmad, M; Kaiser, C; Jornvall, H; Eklund, H; Hoog, JO; Ramaswamy, S
      Crystal structure of sorbitol dehydrogenase

      CHEMICO-BIOLOGICAL INTERACTIONS
    27. Umeda, M; Otsuka, Y; Ii, T; Matsuura, T; Shibati, H; Ota, H; Sakurabayashi, I
      Determination of D-sorbitol in human erythrocytes by an enzymatic fluorometric method with an improved deproteinization procedure

      ANNALS OF CLINICAL BIOCHEMISTRY
    28. Chakrabarti, S; Cukiernik, M; Hileeto, D; Evans, T; Chen, S
      Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    29. Costantino, L; Rastelli, G; Gamberini, MC; Barlocco, D
      Pharmacological approaches to the treatment of diabetic complications

      EXPERT OPINION ON THERAPEUTIC PATENTS
    30. Mowri, HO; Frei, B; Keaney, JF
      Glucose enhancement of LDL oxidation is strictly metal ion dependent

      FREE RADICAL BIOLOGY AND MEDICINE
    31. Varlet, D; Fourmaintraux, E; Depreux, P; Lesieur, D
      Synthesis of 4-[4 '-(N-N-dimethylsulfamoyl)piperazin-1-yl]-pyridine derivatives as sorbitol dehydrogenase potential inhibitors

      HETEROCYCLES
    32. Yasunari, K; Kohno, M; Kano, H; Minami, M; Yoshikawa, J
      Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose

      HYPERTENSION
    33. Keegan, A; Jack, AM; Cotter, MA; Cameron, NE
      Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    34. Hamada, Y; Nakamura, J; Naruse, K; Komori, T; Kato, K; Kasuya, Y; Nagai, R; Horiuchi, S; Hotta, N
      Epalrestat, an aldose reductase inhibitor, reduces the levels of N-epsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytesfrom diabetic patients

      DIABETES CARE
    35. Sellers, DJ; Chess-Williams, R
      The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats

      JOURNAL OF AUTONOMIC PHARMACOLOGY
    36. Dunlop, M
      Aldose reductase and the role of the polyol pathway in diabetic nephropathy

      KIDNEY INTERNATIONAL
    37. Dunlop, ME; Muggli, EE
      Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress

      KIDNEY INTERNATIONAL
    38. Sellers, DJ; Chess-Williams, R
      The effects of Streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    39. Naruse, K; Nakamura, J; Hamada, Y; Nakayama, M; Chaya, S; Komori, T; Kato, K; Kasuya, Y; Miwa, K; Naruse, K; Hotta, N
      Aldose reductase inhibition prevents glucose-induced apoptosis in culturedbovine retinal microvascular pericytes

      EXPERIMENTAL EYE RESEARCH
    40. Obrosova, IG; Fathallah, L; Greene, DA
      Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid

      EUROPEAN JOURNAL OF PHARMACOLOGY
    41. Hohman, TC; Cotter, MA; Cameron, NE
      ATP-sensitive K+ channel effects on nerve function, Na+, K+ ATPase, and glutathione in diabetic rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    42. Cruz, JWMC; Oliveira, MA; Hohman, TC; Fortes, ZB
      Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    43. Obrosova, IG; Fathallah, L
      Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study

      DIABETOLOGIA
    44. Chan, NN; Vallance, P; Colhoun, HM
      Nitric oxide and vascular responses in Type I diabetes

      DIABETOLOGIA
    45. Bell, RC; Carlson, JC; Storr, KC; Herbert, K; Sivak, J
      High-fructose feeding of streptozotocin-diabetic rats is associated with increased cataract formation and increased oxidative stress in the kidney

      BRITISH JOURNAL OF NUTRITION
    46. Lee, YM; Kim, H; Choi, HS; Kang, BH; Han, YB; Kim, SJ
      Effects of water extract of 1 : 1 mixture of Phellodendron cortex and Aralia cortex on polyol pathway and oxidative damage in lenses of diabetic rats

      PHYTOTHERAPY RESEARCH
    47. Suzuki, K; Kawamura, T; Sakakibara, F; Sasaki, H; Sano, T; Sakamoto, N; Hotta, N
      Effect of aldose reductase inhibitors on glucose-induced changes in sorbitol and myo-inositol metabolism in human neutrophils

      DIABETIC MEDICINE
    48. Pugliese, G; Pricci, F; Romeo, G; Leto, G; Amadio, L; Lacobini, C; Di Mario, U
      Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    49. Suzuki, T; Mizuno, K; Yashima, S; Watanabe, K; Taniko, K; Suzuki, T; Yabe-Nishimura, C
      Characterization of polyol pathway in Schwann cells isolated from adult rat sciatic nerves

      JOURNAL OF NEUROSCIENCE RESEARCH
    50. Herbert, KL; Sivak, JG; Bell, RC
      Effect of diabetes and fructose/non-fructose diet on the optical quality (cataracts) of the rat lens

      CURRENT EYE RESEARCH
    51. Secchi, EF; Lizak, MJ; Sato, S; Kador, PF
      3-fluoro-3-deoxy-D-galactose: A new probe for studies on sugar cataract

      CURRENT EYE RESEARCH
    52. Vincent, TE; Mendiratta, S; May, JM
      Inhibition of aldose reductase in human erythrocytes by vitamin C

      DIABETES RESEARCH AND CLINICAL PRACTICE
    53. Obrosova, IG; Stevens, MJ
      Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    54. Inoki, K; Haneda, M; Maeda, S; Koya, D; Kikkawa, R
      TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells

      KIDNEY INTERNATIONAL
    55. Zhang, SL; Filep, JG; Hohman, TC; Tang, SS; Ingelfinger, JR; Chan, JSD
      Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells

      KIDNEY INTERNATIONAL
    56. Kubo, E; Miyoshi, N; Fukuda, M; Akagi, Y
      Cataract formation through the polyol pathway is associated with free radical production

      EXPERIMENTAL EYE RESEARCH
    57. Kasuya, Y; Ito, M; Nakamura, J; Hamada, Y; Nakayama, M; Chaya, S; Komori, T; Naruse, K; Nakashima, E; Kato, K; Koh, N; Hotta, N
      An aldose redutase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs

      DIABETOLOGIA
    58. Terata, K; Coppey, LJ; Davidson, EP; Dunlap, JA; Gutterman, DD; Yorek, MA
      Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction

      BRITISH JOURNAL OF PHARMACOLOGY
    59. Obrosova, IG; Fathallah, L; Lang, HJ
      Interaction between osmotic and oxidative stress in diabetic precataractous lens - Studies with a sorbitol dehydrogenase inhibitor

      BIOCHEMICAL PHARMACOLOGY
    60. Kasuya, Y; Nakamura, J; Hamada, Y; Nakayama, M; Sasaki, H; Komori, T; Chaya, S; Watanabe, G; Naruse, K; Nakashima, E; Kato, K; Hotta, N
      An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    61. Tomlinson, DR
      Future prevention and treatment of diabetic neuropathy

      DIABETES & METABOLISM
    62. COTTER MA; CAMERON NE; HOHMAN TC
      CORRECTION OF NERVE-CONDUCTION AND ENDONEURIAL BLOOD-FLOW DEFICITS BYTHE ALDOSE REDUCTASE INHIBITOR, TOLRESTAT, IN DIABETIC RATS

      Journal of the peripheral nervous system
    63. BURNARD SL; MCMURCHIE EJ; LEIFERT WR; PATTEN GS; MUGGLI R; RAEDERSTORFF D; HEAD RJ
      CILAZAPRIL AND DIETARY GAMMA-LINOLENIC ACID PREVENT THE DEFICIT IN SCIATIC-NERVE CONDUCTION-VELOCITY IN THE STREPTOZOTOCIN-DIABETIC RAT

      Journal of diabetes and its complications
    64. TOMLINSON DR; DEWHURST M; STEVENS EJ; OMAWARI N; CARRINGTON AL; VO PA
      REDUCED NERVE BLOOD-FLOW IN DIABETIC RATS - RELATIONSHIP TO NITRIC-OXIDE PRODUCTION AND INHIBITION OF ALDOSE REDUCTASE

      Diabetic medicine
    65. Zahner, B; Hilz, MJ
      Therapy of diabetic polyneuropathy - present and future perspectives

      NERVENHEILKUNDE
    66. LINDSTAD RI; KOLL P; MCKINLEYMCKEE JS
      SUBSTRATE-SPECIFICITY OF SHEEP LIVER SORBITOL DEHYDROGENASE

      Biochemical journal
    67. YOSHIDA M; SUGIYAMA Y; AKAIKE N; ASHIZAWA N; AOTSUKA T; OHBAYASHI S; MATSUURA A
      AMELIORATION OF NEUROVASCULAR DEFICITS IN DIABETIC RATS BY A NOVEL ALDOSE REDUCTASE INHIBITOR, GP-1447 - MINOR CONTRIBUTION OF NITRIC-OXIDE

      Diabetes research and clinical practice
    68. HAYASHI R; HAYAKAWA N; MAKINO M; NAGATA M; KAKIZAWA H; UCHIMURA K; HAMADA M; AONO T; FUJITA T; SHINOHARA R; NAGASAKA A; ITOH M
      CHANGES IN ERYTHROCYTE SORBITOL CONCENTRATIONS MEASURED USING AN IMPROVED ASSAY SYSTEM IN PATIENTS WITH DIABETIC COMPLICATIONS AND TREATED WITH ALDOSE REDUCTASE INHIBITOR

      Diabetes care
    69. YABENISHIMURA C
      ALDOSE REDUCTASE IN GLUCOSE TOXICITY - A POTENTIAL TARGET FOR THE PREVENTION OF DIABETIC COMPLICATIONS

      Pharmacological reviews
    70. MCAULIFFE AV; BROOKS BA; FISHER EJ; MOLYNEAUX LM; YUE DK
      ADMINISTRATION OF ASCORBIC-ACID AND AN ALDOSE REDUCTASE INHIBITOR (TOLRESTAT) IN DIABETES - EFFECT ON URINARY ALBUMIN EXCRETION

      Nephron
    71. Cooper, ME; Gilbert, RE; Epstein, M
      Pathophysiology of diabetic nephropathy

      METABOLISM-CLINICAL AND EXPERIMENTAL
    72. MIZISIN AP; KALICHMAN MW; BACHE M; DINES KC; DISTEFANO PS
      NT-3 ATTENUATES FUNCTIONAL AND STRUCTURAL DISORDERS IN SENSORY NERVESOF GALACTOSE-FED RATS

      Journal of neuropathology and experimental neurology
    73. KURUVILLA R; EICHBERG J
      DEPLETION OF PHOSPHOLIPID ARACHIDONOYL-CONTAINING MOLECULAR-SPECIES IN A HUMAN SCHWANN-CELL LINE GROWN IN ELEVATED GLUCOSE AND THEIR RESTORATION BY AN ALDOSE REDUCTASE INHIBITOR

      Journal of neurochemistry
    74. Kawasaki, Y; Fujii, J; Miyazawa, N; Hoshi, Y; Okado, A; Tano, Y; Taniguchi, N
      Specific detections of the early process of the glycation reaction by fructose and glucose in diabetic rat lens

      FEBS LETTERS
    75. COTTER MA; CAMERON NE
      CORRECTION OF NEUROVASCULAR DEFICITS IN DIABETIC RATS BY BETA(2)-ADRENOCEPTOR AGONIST AND ALPHA(1)-ADRENOCEPTOR ANTAGONIST TREATMENT - INTERACTIONS WITH THE NITRIC-OXIDE SYSTEM

      European journal of pharmacology
    76. HOHMAN TC; ELKABBANI O; MALAMAS MS; LAI KD; PUTILINA T; MCGOWAN MH; WANE YQ; CARPER DA
      PROBING THE INHIBITOR-BINDING SITE OF ALDOSE REDUCTASE WITH SITE-DIRECTED MUTAGENESIS

      European journal of biochemistry
    77. LINDSAY RM; JAMIESON NSD; WALKER SA; MCGUIGAN CC; SMITH W; BAIRD JD
      TISSUE ASCORBIC-ACID AND POLYOL PATHWAY METABOLISM IN EXPERIMENTAL DIABETES

      Diabetologia
    78. NG DTF; LEE FK; SONG ZT; CALCUTT NA; LEE LW; CHUNG SSM; CHUNG SK
      EFFECTS OF SORBITOL DEHYDROGENASE-DEFICIENCY ON NERVE-CONDUCTION IN EXPERIMENTAL DIABETIC MICE

      Diabetes
    79. Scott, ME; Viola, RE
      The use of fluoro- and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway

      CARBOHYDRATE RESEARCH
    80. COSTANTINO L; RASTELLI G; CIGNARELLA G; VIANELLO P; BARLOCCO D
      NEW ALDOSE REDUCTASE INHIBITORS AS POTENTIAL AGENTS FOR THE PREVENTION OF LONG-TERM DIABETIC COMPLICATIONS

      Expert opinion on therapeutic patents
    81. FELDMAN EL; STEVENS MJ; GREENE DA
      PATHOGENESIS OF DIABETIC NEUROPATHY

      Clinical neuroscience
    82. HOTTA N
      RETINOPATHY

      Internal medicine
    83. OATES PJ
      THE POLYOL PATHWAY - A CULPRIT IN DIABETIC NEUROPATHY

      Neuroscience research communications
    84. NAGAOKA S; SUGIMOTO Y; YARA M; KOGA K
      CHANGES IN THE ACTIVITIES OF ALDOLASE AND OTHER ENZYMES FOR CARBOHYDRATE-METABOLISM DURING EMBRYONIC AND POSTEMBRYONIC DEVELOPMENT OF BOMBYX-MORI

      Archives of insect biochemistry and physiology
    85. HOTTA N; NAKAMURA J; SAKAKIBARA F; HAMADA Y; HARA T; MORI K; NAKASHIMA E; SASAKI H; KASAMA N; INUKAI S; KOH N
      ELECTRORETINOGRAM IN SUCROSE-FED DIABETIC RATS TREATED WITH AN ALDOSEREDUCTASE INHIBITOR OR AN ANTICOAGULANT

      American journal of physiology: endocrinology and metabolism
    86. NAKAMURA J; KOH N; SAKAKIBARA F; HAMADA Y; WAKAO T; SASAKI H; MORI K; NAKASHIMA E; NARUSE K; HOTTA N
      DIABETIC NEUROPATHY IN SUCROSE-FED OTSUKA LONG-EVANS TOKUSHIMA FATTY RATS - EFFECT OF AN ALDOSE REDUCTASE INHIBITOR, TAT

      Life sciences
    87. MIZISIN AP; BACHE M; DISTEFANO PS; ACHESON A; LINDSAY RM; CALCUTT NA
      BDNF ATTENUATES FUNCTIONAL AND STRUCTURAL DISORDERS IN NERVES OF GALACTOSE-FED RATS

      Journal of neuropathology and experimental neurology
    88. KARIHALOO AK; JOSHI K; CHOPRA JS
      EFFECT OF SORBINIL AND ASCORBIC-ACID ON MYOINOSITOL TRANSPORT IN CULTURED RAT SCHWANN-CELLS EXPOSED TO ELEVATED EXTRACELLULAR GLUCOSE

      Journal of neurochemistry
    89. TILTON RG; KAWAMURA T; CHANG KC; IDO Y; BJERCKE RJ; STEPHAN CC; BROCK TA; WILLIAMSON JR
      VASCULAR DYSFUNCTION INDUCED BY ELEVATED GLUCOSE-LEVELS IN RATS IS MEDIATED BY VASCULAR ENDOTHELIAL GROWTH-FACTOR

      The Journal of clinical investigation
    90. KANDA M; ETO K; TANABE N; SUGIYAMA A; HASHIMOTO K; UENO A
      EFFECTS OF ONO-2235, AN ALDOSE REDUCTASE INHIBITOR, ON MUSCARINIC RECEPTORS AND CONTRACTILE RESPONSE OF THE URINARY-BLADDER IN RATS WITH STREPTOZOTOCIN-INDUCED DIABETES

      Japanese Journal of Pharmacology
    91. CARR IM; MARKHAM AF; COLETTA PL
      IDENTIFICATION AND CHARACTERIZATION OF A SEQUENCE RELATED TO HUMAN SORBITOL DEHYDROGENASE

      European journal of biochemistry
    92. KASHIWAGI A; NISHIO Y; ASAHINA T; IKEBUCHI M; HARADA N; TANAKA Y; TAKAHARA N; TAKI H; OBATA T; HIDAKA H; SAEKI Y; KIKKAWA R
      PYRUVATE IMPROVES DELETERIOUS EFFECTS OF HIGH GLUCOSE ON ACTIVATION OF PENTOSE-PHOSPHATE PATHWAY AND GLUTATHIONE REDOX CYCLE IN ENDOTHELIAL-CELLS

      Diabetes
    93. MARINI I; BUCCHIONI L; BORELLA P; DELCORSO A; MURA U
      SORBITOL DEHYDROGENASE FROM BOVINE LENS - PURIFICATION AND PROPERTIES

      Archives of biochemistry and biophysics
    94. MIZISIN AP; POWELL HC
      SCHWANN-CELL CHANGES INDUCED AS EARLY AS ONE WEEK AFTER GALACTOSE INTOXICATION

      Acta Neuropathologica
    95. SULLIVAN R
      CONTRIBUTIONS TO SENESCENCE - NONENZYMATIC GLYCOSYLATION OF PROTEINS

      Archives of physiology and biochemistry
    96. HAMADA Y; ARAKI N; HORIUCHI S; HOTTA N
      ROLE OF POLYOL PATHWAY IN NONENZYMATIC GLYCATION

      Nephrology, dialysis, transplantation
    97. NAGANO S; KUROKAWA M; EBARA T; NAITO H; SAKAMAKI R; FURUKAWA S; HIRANO T; MAEDA M; TSUJI A
      DECREASE OF SERUM ASCORBIC-ACID CONCENTRATIONS IN PATIENTS WITH DIABETIC MACROANGIOPATHY

      Journal of nutritional science and vitaminology
    98. KICIC E; PALMER TN
      INCREASED WHITE CELL ALDOSE REDUCTASE MESSENGER-RNA LEVELS IN DIABETIC-PATIENTS

      Diabetes research and clinical practice
    99. ROBISON WG; LAVER NM; JACOT JL; GLOVER JP; BASSO MD; BLOUIN P; HOHMAN TC
      DIABETIC-LIKE RETINOPATHY AMELIORATED WITH THE ALDOSE REDUCTASE INHIBITOR WAY-121,509

      Investigative ophthalmology & visual science
    100. BEYERMEARS A; MISTRY K; DIECKE FPJ; CRUZ E
      ZOPOLRESTAT PREVENTION OF PROTEINURIA, ALBUMINURIA AND CATARACTOGENESIS IN DIABETES-MELLITUS

      Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 21:52:41